256 related articles for article (PubMed ID: 26974655)
1. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
Miller JL; Tyrrell BE; Zitzmann N
Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
[TBL] [Abstract][Full Text] [Related]
3. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.
Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N
Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells.
Perera N; Brun J; Alonzi DS; Tyrrell BE; Miller JL; Zitzmann N
Antiviral Res; 2022 Mar; 199():105269. PubMed ID: 35227758
[TBL] [Abstract][Full Text] [Related]
6. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
[TBL] [Abstract][Full Text] [Related]
7. Iminosugar antivirals: the therapeutic sweet spot.
Alonzi DS; Scott KA; Dwek RA; Zitzmann N
Biochem Soc Trans; 2017 Apr; 45(2):571-582. PubMed ID: 28408497
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S
Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111
[TBL] [Abstract][Full Text] [Related]
9. Iminosugars: A host-targeted approach to combat Flaviviridae infections.
Evans DeWald L; Starr C; Butters T; Treston A; Warfield KL
Antiviral Res; 2020 Dec; 184():104881. PubMed ID: 32768411
[TBL] [Abstract][Full Text] [Related]
10. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
Chang J; Block TM; Guo JT
Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
[TBL] [Abstract][Full Text] [Related]
12. Iminosugars: Promising therapeutics for influenza infection.
Tyrrell BE; Sayce AC; Warfield KL; Miller JL; Zitzmann N
Crit Rev Microbiol; 2017 Sep; 43(5):521-545. PubMed ID: 27931136
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the selectivity of ER α-glucosidase inhibitors.
O'Keefe S; Roebuck QP; Nakagome I; Hirono S; Kato A; Nash R; High S
Glycobiology; 2019 Jul; 29(7):530-542. PubMed ID: 30976784
[TBL] [Abstract][Full Text] [Related]
14. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
Warfield KL; Plummer E; Alonzi DS; Wolfe GW; Sampath A; Nguyen T; Butters TD; Enterlein SG; Stavale EJ; Shresta S; Ramstedt U
Viruses; 2015 May; 7(5):2404-27. PubMed ID: 25984714
[TBL] [Abstract][Full Text] [Related]
15. Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response.
Sayce AC; Martinez FO; Tyrrell BE; Perera N; Hill ML; Dwek RA; Miller JL; Zitzmann N
Immunology; 2021 Nov; 164(3):587-601. PubMed ID: 34287854
[TBL] [Abstract][Full Text] [Related]
16. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
[TBL] [Abstract][Full Text] [Related]
17. Synthetic 1-deoxynojirimycin N-substituted peptides offer prolonged disruption to N-linked glycan processing.
Aguilar AL; Escribano J; Wentworth P; Butters TD
ChemMedChem; 2014 Dec; 9(12):2809-13. PubMed ID: 25352425
[TBL] [Abstract][Full Text] [Related]
18. An iminosugar with potent inhibition of dengue virus infection in vivo.
Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
20. Iminosugars With Endoplasmic Reticulum α-Glucosidase Inhibitor Activity Inhibit ZIKV Replication and Reverse Cytopathogenicity
Bhushan G; Lim L; Bird I; Chothe SK; Nissly RH; Kuchipudi SV
Front Microbiol; 2020; 11():531. PubMed ID: 32373079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
